Home / Articles / Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M

Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M

Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M Image
  • Posted on 04th Aug, 2022 14:33 PM
  • 1129 Views

U.S. pharmaceutical giant Gilead Sciences has announced plans to acquire Oxford University biotech spinout company MiroBio in an all-cash deal worth $405 million. MiroBio is a clinical-stage company focused on developing treatments to “restore immune balance” in autoimmune patients, whi…